pharmaphorum

DECEMBER 15, 2021

Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. But the difference between them is not like the choice between “agreeing” and “aligning” or “getting together later” and “taking this offline.” Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery.

Communication 145

Communication Hospitals 145

Outsourcing Pharma

DECEMBER 13, 2021

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.

140

140

Fierce Healthcare

DECEMBER 3, 2021

After court-ordered injunctions, Cleveland Clinic, HCA and other providers hit pause on workforce vaccine mandates. dmuoio. Fri, 12/03/2021 - 16:30.

Vaccines 135

Vaccines 135

Pharma Marketing Network

DECEMBER 17, 2021

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. In this article, R.J. Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022.

Customer Service 105

Customer Service Vaccines Communication 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fossil Remedies

DECEMBER 23, 2021

When you run a PCD Pharma Company , your prime objective is to earn profit. For that,it is essential to generate a greater number of queries. When you do it, the business performs well. When it performs well, you enhance your market position. Bigger sales mean your company is viewed as a successful company. What are the different ways of generating enquiries?

86

86

Pharma Times

DECEMBER 9, 2021

In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services

51

51

Outsourcing Pharma

DECEMBER 13, 2021

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies 145

Fierce Healthcare

DECEMBER 3, 2021

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey. rtorrence. Fri, 12/03/2021 - 16:07.

145

145

Pharma Marketing Network

DECEMBER 17, 2021

Big pharma has compelling reasons to change the way business gets done. The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. Leaders are hard at work focusing their efforts on how to use sustainability as a platform for innovation. Step one is to assess your corporate social responsibility (CSR) policies and ensure actions are integrated across the organization.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Outsourcing Pharma

DECEMBER 15, 2021

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.

141

141

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Outsourcing Pharma

DECEMBER 7, 2021

According to a leader from Cytoreason, AI isnât necessarily the best or only tool suited to discover new and novel therapiesâit might take a human touch.

144

144

pharmaphorum

DECEMBER 13, 2021

UCB has the positive result it was hoping for in its phase 3 trial of anti-neonatal FC receptor (FcRn) antibody rozanolixizumab for autoimmune disease generalised myasthenia gravis (gMG), setting up regulatory filings next year. The MycarinG study met its primary endpoint, demonstrating a “statistically significant and clinically meaningful” improvement from baseline in the myasthenia gravis-activities of daily living (MG-ADL) score, said the Belgian drugmaker.

FDA 131

FDA 131

pharmaphorum

DECEMBER 21, 2021

Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. South San Francisco-based Amunix specialises in T-cell engager and cytokine-based treatments for solid tumours, and is planning to advance its lead programme AMX-818 – a cell-based therapy which targets HER2-expressing cancers – into the clinic next year.

124

124

pharmaphorum

DECEMBER 17, 2021

The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced by the data submitted for the drug. The companies had already indicated that the CHMP looked likely to turn down their marketing application for Aduhelm (aducanumab), but the decision nevertheless is a heavy blow, coming as take-up of the drug has pretty much stalled in the US.

Documentation 124

Documentation 124

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

DECEMBER 30, 2021

Johnson & Johnson’s much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second candidate. The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab.

FDA 122

FDA Chemotherapy Immunization 122

pharmaphorum

DECEMBER 22, 2021

A group of 15 digital health startups have joined a programme set up by the US federal government to address health inequality and mitigate the effects if the COVID-19 pandemic. The PandemicX accelerator, launched by the Department of Health and Human Services, is focused on “using digital tools and publicly accessible data to eliminate disparities and tackle drivers of inequity exacerbated by COVID-19.” Companies that have been invited to take part will get “curriculum, mentor

Vaccines 122

Vaccines 122

pharmaphorum

DECEMBER 3, 2021

An online training academy that aims to raise the digital skills of NHS health and care workers is due to open its virtual doors next March, according to the Organisation for the Review of Care and Health Apps (ORCHA). The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.

121

121

Fierce Healthcare

DECEMBER 1, 2021

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk. rtorrence. Wed, 12/01/2021 - 17:47.

144

144

pharmaphorum

DECEMBER 6, 2021

UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal. BenevolentAI will merge with Odyssey Acquisition, a SPAC set up by investment bankers Michael and Yoel Zaoui that lists former Sanofi chief executive Olivier Brandicourt among its advisors – in a deal that will raise some €390 million in proceeds.

FDA 119

FDA 119

pharmaphorum

DECEMBER 2, 2021

The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech’s antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in lab testing. Xevudy (sotrovimab) is the second COVID-19 antibody to be approved by the MHRA after Roche/Regeneron’s Ronapreve (casirivimab and imdevimab), which got a green light during the summer.

Vaccines 119

Vaccines 119

Fierce Healthcare

DECEMBER 3, 2021

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most. rking. Fri, 12/03/2021 - 16:14.

137

137

pharmaphorum

DECEMBER 23, 2021

The FDA has published draft guidance on how digital health technologies (DHTs) like smart and wearable devices can be used to capture data remotely from patients in clinical trials – an approach that has come to the fore since the start of the pandemic. The new guidance sets out the regulator’s current thinking on how trial sponsors to incorporate DHTs in the design of studies of drugs or medical devices.

FDA 118

FDA Documentation 118

Fierce Healthcare

DECEMBER 8, 2021

Amazon launches new elder care subscription service Alexa Together with emergency assistance, fall detection. rtorrence. Wed, 12/08/2021 - 11:21.

131

131

Outsourcing Pharma

DECEMBER 15, 2021

The Parkinsonâs Progression Markers Initiative, built using Evidation Healthâs research platform, aims to triple enrollment and recruit online participants.

126

126

Fierce Healthcare

DECEMBER 3, 2021

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19. rking. Fri, 12/03/2021 - 12:25.

141

141

Fierce Healthcare

DECEMBER 2, 2021

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy. hlandi. Thu, 12/02/2021 - 06:26.

145

145

Fierce Healthcare

DECEMBER 3, 2021

Hack targets Planned Parenthood, exposing personal information of 400K patients. rtorrence. Fri, 12/03/2021 - 10:13.

145

145

pharmaphorum

DECEMBER 21, 2021

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives. Such a fast turnaround would not have been possible without advanced analytics and the troves of intelligence that scientists had at their disposal.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 115

Fierce Healthcare

DECEMBER 12, 2021

Hospitals across the country running out of beds, reducing surgeries amid latest COVID surge. hlandi. Sun, 12/12/2021 - 22:15.

Hospitals 138

Hospitals 138

Fierce Healthcare

DECEMBER 21, 2021

More than 40 organizations, unions urge OSHA to extend protections for healthcare workers. agliadkovskaya. Tue, 12/21/2021 - 15:57.

135

135

Fierce Healthcare

DECEMBER 7, 2021

With COVID-19 resurging, New York halts electives at 32 hospitals to preserve capacity. dmuoio. Tue, 12/07/2021 - 15:03.

Hospitals 141

Hospitals 141

Fierce Healthcare

DECEMBER 10, 2021

Health services M&A deals surged in 2021. Here are key trends that could impact deal-making next year, PwC reports. hlandi. Fri, 12/10/2021 - 14:55.

126

126

Fierce Healthcare

DECEMBER 21, 2021

2022 forecast: Investors will double down on these hot digital health markets. hlandi. Tue, 12/21/2021 - 16:45.

145

145

Fierce Healthcare

DECEMBER 21, 2021

Digital health startups join HHS accelerator to tackle COVID health inequities. rtorrence. Tue, 12/21/2021 - 11:06.

142

142